Bausch+Lomb Results Presentation Deck

Reconciliation of Reported Revenue to Organic Revenue ¹,2 and Organic Revenue Growth 1.2 ($M) (Quarter-to-Date and Year-to-Date) Bausch+Lomb Vision Care Surgical Ophthalmic Pharmaceuticals Total Bausch + Lomb Bausch + Lomb Vision Care Surgical Ophthalmic Pharmaceuticals Total Bausch + Lomb BAUSCH + LOMB 1. 2. 3. Revenue as Reported 598 172 172 942 Revenue as Reported 1,747 530 495 2,772 Calculation of Organic Revenue for the Three Months Ended September 30, 2022 September 30, 2021 Changes in Exchange Rates 34 13 8 55 Changes in Exchange Rates Organic Revenue (Non- GAAP) ¹,2 82 30 18 130 632 185 180 997 (1) Calculation of Organic Revenue for the Nine Months Ended September 30, 2022 September 30, 2021 Organic Revenue (Non- GAAP)¹,2 Revenue as Reported 1,829 560 513 2,902 605 173 171 949 Revenue as Reported Divestitures and Discontinuations 1,717 520 527 2,764 Divestitures and Discontinuations Organic Revenue (Non- GAAP 1,2 605 172 171 948 Organic Revenue (Non- GAAP) ¹,2 1,717 513 527 2,757 Change in Reported Revenue Amount 1 (7) Amount Pct. Change in Reported Revenue 30 10 (32) 8 -1% -1% 1% -1% Pct. 2% 2% -6% 0% Change in Organic Revenue ¹,2 Amount 27 13 9 49 Amount Change in Organic Revenue 112 47 (14) Pct. 145 4% 8% 5% 5% Pct. 7% 9% -3% 5% This is a non-GAAP measure or non-GAAP ratio. See Slide 2 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. 1,2 37

View entire presentation